Graham Collins
@graham74GC
Followers
17K
Following
11K
Media
2K
Statuses
9K
Associate Professor of Haematology and lymphoma specialist at Oxford Cancer and Haematology centre. Christian, husband and father.
Opinions are mine
Joined December 2013
A real pleasure to spend the last 2 days with friends and colleagues from the Sri Lanka College of Haematology. Humbling to hear the challenges they face and inspiring to see their dedication to patient care.
2
1
31
Very interesting data which will go into the ongoing debate of how best to treat double hit lymphoma. #lymsm
Population-Wide Introduction of Dose-Adjusted EPOCH-R In High-grade B-cell Lymphoma with MYC/BCL2 Rearrangements, DLBCL Morphology | Blood Advances | American Society of Hematology
1
3
36
Treatment of relapsed and refractory follicular lymphoma: which treatment for which patient for which line of therapy? https://t.co/rFW0XwVqPT Wonderful to work with Dr Laurie Sehn on this review highlighting our approach to relapsed FL #lymsm @BloodPortfolio @WilmotCancer
ashpublications.org
Although there have been many therapeutic advances in follicular lymphoma (FL) in recent years, important questions remain about how best to integrate emer
0
14
51
Neelapu - long term zuma5 FU, axi-cel in iNHL (mainly FL) • 159 pts, 5y FU • 75% CRR, median PFS 62.2mo • NRM 15% • ongoing response correlated with enriched naive T-cells in axi-cel product. #lymsm
https://t.co/1Dh5HzRimp
2
12
39
A real honour to be at the Sri Lankan college of haematology HaemIcon 2025.
1
1
9
▶️New #CLL @BritSocHaem UK guidelines including recommendations on I+V, A+V, Zanubrutinib, Pirtobrutinib and much more! #Lymsm #CLL British Journal of Haematology | Wiley Online Library https://t.co/1NVleN62NY
3
33
88
Hot off the press! Lewis et al. Wonderful to see this international investigator initiated academic RCT published open access in @TheLancet today Fantastic UK+Nordic collaboration #MCL #Lymsm
https://t.co/Fd3DkusXlR
thelancet.com
To our knowledge, this is the first randomised trial in untreated mantle-cell lymphoma to demonstrate significant improvement in progression-free survival for ibrutinib–rituximab compared to immuno...
1
16
63
Thanks to all involved in making this course so successful.
It's been a fantastic year for #LymphomaManagement! You can now catch up on all the presentation videos and download copies of the slides. Register for on-demand access 👉 https://t.co/LvbNrNSxM8
@graham74GC @tobyeyre82 @OxfordHaem #LymSM
1
1
12
Lymphoma is the UK’s most common #BloodCancer. As we come to the end of #BloodCancerAwarenessMonth, let's keep talking about the symptoms. Please repost so that more people know what to look out for. Find out more 👉 https://t.co/H6E5iWzRLO
#LetsTalkLymphoma #Lymphoma
1
11
12
Professor Kim Linton will discuss marginal zone #Lymphoma in this final week of our online #LymphomaManagement course. Don't miss out and book now 👉 https://t.co/LvbNrNSxM8
@graham74GC @tobyeyre82 #LymSM #Haematology
1
2
5
Five-Year Outcomes of the POLARIX Study Comparing Pola-R-CHP and R-CHOP in Patients With Diffuse Large B-Cell Lymphoma | Journal of Clinical Oncology
ascopubs.org
In the POLARIX study (ClinicalTrials.gov identifier: NCT03274492), polatuzumab vedotin plus rituximab, cyclophosphamide, doxorubicin, and prednisone (Pola-R-CHP) showed a significant progression-free...
2
22
74
Great to have the fantastic Beth Phillips speak on the challenging area of relapsed Hodgkin and @CwynKate give a masterful overview of T-cell lymphoma. Wish you had signed up? You still can! And hear all the talks / Q&A on playback. Don’t miss it!
Week 2 of #LymphomaManagement kicks off tonight, continuing our engaging programme for healthcare professionals working in #Lymphoma. Booking is still open 👉 https://t.co/LvbNrNSxM8
@graham74GC @tobyeyre82 @OxfordHaem #LymSM
2
2
7
A look at key updates and trials expected in Lymphoma in 2025 Explore more about oncology conferences, top trials, and reactions from oncologists: https://t.co/VJu7MflQA0
#LARVOL #Oncology #CancerResearch #CancerData #OncologyInsights #Lymphoma #WorldLymphomaAwarenessDay
1
11
23
Fantastic to have @CwynKate speak on the weird and wonderful field of T-cell Lymphoma. Join us next week!
#LymphomaManagement starts tonight! Professor Kate Cwynarski will cover Peripheral T-cell #Lymphoma during this online course for healthcare professionals. Still to book your place? Book now and don't miss out 👉 https://t.co/LvbNrNSxM8
@graham74GC @tobyeyre82 @CwynKate #LymSM
3
4
15
Thank you for joining Week 1 of #LymphomaManagement! Covering High-grade non-Hodgkin #Lymphoma: diagnostics and #DLBCL, it was an evening of expertise shared! You can still book to join us for the rest of the course 👉 https://t.co/LvbNrNSxM8
@graham74GC @tobyeyre82 #LymSM
0
4
4
‼️See below terrific opportunity for a postdoc post with a leading group in Oxford, super exciting science, now being applied to myeloid malignancies! 🔥🔥👇@UniofOxford @Ludwig_Cancer @ASH_hematology @CR_UK
Please share: we’re recruiting a postdoctoral fellow – applications open until September 15! To lead genomics data analysis of an exciting translational project in sAML cancer, supportive environment, and access to unique in-house technologies. https://t.co/plDpkuSAnW
0
7
15
The online #LymphomaManagement course starts tonight! We are excited to bring healthcare professionals a programme of expert speakers in #Lymphoma to refine and refresh your knowledge. Booking is still open 👉 https://t.co/LvbNrNSxM8
@graham74GC @tobyeyre82 @OxfordHaem #LymSM
0
3
5
Here we go with Lymphoma Management 2026! Nearly 400 people enrolled. This week: • why is lymphoma so interesting? • integrated lymphoma diagnostics • first line treatment of DLBCL • relapsed DLBCL. Thank you to Cathy Burton, Chris Fox and Andy Davies A real feast! #lymsm
1
4
29
Tomorrow is the start of the new Lymphoma Management course. Sign up to watch the talks which are bang up to date, and to engage in the love Q and A.
Our online #LymphomaManagement course for healthcare professionals starts tomorrow. Dr Beth Phillips will be talking about relapsed and refractory #HodgkinLymphoma. Book now 👉 https://t.co/LvbNrNSxM8
@graham74GC @tobyeyre82 #LymSM #Lymphoma #Haematology
2
3
12
#Lymphoma can develop at any age – it's the UK's most common #BloodCancer. This #BloodCancerAwarenessMonth, we want to encourage conversations about lymphoma, to help raise awareness. Find out more 👉 https://t.co/qkxZeKmXnx
1
5
7